Literature DB >> 10562653

The genetics of age-related macular degeneration.

M B Gorin1, J C Breitner, P T De Jong, G S Hageman, C C Klaver, M H Kuehn, J M Seddon.   

Abstract

Age-related macular degeneration (AMD) is increasingly recognized as a complex genetic disorder in which one or more genes contribute to an individual's susceptibility for developing the condition. Twin and family studies as well as population-based genetic epidemiologic methods have convincingly demonstrated the importance of genetics in AMD, though the extent of heritability, the number of genes involved, and the phenotypic and genetic heterogeneity of the condition remain unresolved. The extent to which other hereditary macular dystrophies such as Stargardts disease, familial radial drusen (malattia leventinese), Best's disease, and peripherin/RDS-related dystrophy are related to AMD remains unclear. Alzheimer's disease, another late onset, heterogeneous degenerative disorder of the central nervous system, offers a valuable model for identifying the issues that confront AMD genetics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10562653

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  14 in total

1.  Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy.

Authors:  M M LaVail; D Yasumura; M T Matthes; K A Drenser; J G Flannery; A S Lewin; W W Hauswirth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease.

Authors:  Gonçalo R Abecasis; Beverly M Yashar; Yu Zhao; Noor M Ghiasvand; Sepideh Zareparsi; Kari E H Branham; Adam C Reddick; Edward H Trager; Shigeo Yoshida; John Bahling; Elena Filippova; Susan Elner; Mark W Johnson; Andrew K Vine; Paul A Sieving; Samuel G Jacobson; Julia E Richards; Anand Swaroop
Journal:  Am J Hum Genet       Date:  2004-02-16       Impact factor: 11.025

3.  Extension of the SIMLA package for generating pedigrees with complex inheritance patterns: environmental covariates, gene-gene and gene-environment interaction.

Authors:  Mike Schmidt; Elizabeth R Hauser; Eden R Martin; Silke Schmidt
Journal:  Stat Appl Genet Mol Biol       Date:  2005-06-06

4.  Analysis of Hemicentin-1, hOgg1, and E-selectin single nucleotide polymorphisms in age-related macular degeneration.

Authors:  Christine M Bojanowski; Jingsheng Tuo; Emily Y Chew; Karl G Csaky; Chi-Chao Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 5.  [Y402H polymorphism in complement factor H and age-related macula degeneration (AMD)].

Authors:  H P N Scholl; B H F Weber; M M Nöthen; T Wienker; F G Holz
Journal:  Ophthalmologe       Date:  2005-11       Impact factor: 1.059

6.  Race, iris color, and age-related macular degeneration.

Authors:  R N Frank; J E Puklin; C Stock; L A Canter
Journal:  Trans Am Ophthalmol Soc       Date:  2000

Review 7.  Age-related macular degeneration: epidemiology and optimal treatment.

Authors:  Morten la Cour; Jens Folke Kiilgaard; Mogens Holst Nissen
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

8.  Genetic loci that control the size of laser-induced choroidal neovascularization.

Authors:  Kei Nakai; Michael S Rogers; Takashi Baba; Taisaku Funakoshi; Amy E Birsner; Dema S Luyindula; Robert J D'Amato
Journal:  FASEB J       Date:  2009-02-23       Impact factor: 5.191

9.  Late-onset autosomal dominant macular dystrophy with choroidal neovascularization and nonexudative maculopathy associated with mutation in the RDS gene.

Authors:  Shahrokh C Khani; Athanasios J Karoukis; Joyce E Young; Rajesh Ambasudhan; Tracy Burch; Richard Stockton; Richard Alan Lewis; Lori S Sullivan; Stephen P Daiger; Elias Reichel; Radha Ayyagari
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-08       Impact factor: 4.799

10.  Indocyanine green angiography features of Malattia leventinese.

Authors:  E H Souied; N Leveziel; G Querques; J Darmon; G Coscas; G Soubrane
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.